Literature DB >> 7526861

Modeling of prostate specific antigen and human glandular kallikrein structures.

M Vihinen1.   

Abstract

The three dimensional structures of human prostate specific antigen (PSA) and glandular kallikrein (hGK) were modeled based on porcine pancreatic kallikrein A. High sequence similarity and conserved framework of serine proteases enabled accurate modeling. The catalytic site region consisting of catalytic triad, residues forming oxyanion hole and main-chain substrate binding residues were conserved. The substrate specificity pocket of PSA resembles that of chymotrypsin and hGK is most related with tonin. The models were used to predict interactions with substrate and inhibitor molecules. The models are valuable in interpreting mutant and epitope mapping data as well as when modifying properties of the proteases or when developing diagnostic detection methods for prostatic cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7526861     DOI: 10.1006/bbrc.1994.2597

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The crystal structure of the mouse glandular kallikrein-13 (prorenin converting enzyme).

Authors:  D E Timm
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

2.  Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.

Authors:  T Piironen; B O Villoutreix; C Becker; K Hollingsworth; M Vihinen; D Bridon; X Qiu; J Rapp; B Dowell; T Lövgren; K Pettersson; H Lilja
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

3.  Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.

Authors:  B O Villoutreix; H Lilja; K Pettersson; T Lövgren; O Teleman
Journal:  Protein Sci       Date:  1996-05       Impact factor: 6.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.